Estrogen receptor negative status [ER-] Z17.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM Z17.1 became effective on October 1, 2018.
A corresponding procedure code must accompany a Z code if a procedure is performed. Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00 -Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways:
2016 2017 2018 2019 Billable/Specific Code POA Exempt. Z17.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2018/2019 edition of ICD-10-CM Z17.0 became effective on October 1, 2018.
Z17.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z17.1 became effective on October 1, 2021. This is the American ICD-10-CM version of Z17.1 - other international versions of ICD-10 Z17.1 may differ. Z codes represent reasons for encounters.
Listen to pronunciation. (ES-truh-jin reh-SEP-ter PAH-zih-tiv) Describes cells that have a protein that binds to the hormone estrogen. Cancer cells that are estrogen receptor positive may need estrogen to grow.
Listen to pronunciation. (proh-JES-teh-rone reh-SEP-ter PAH-zih-tiv) Describes cells that have a protein that binds to the hormone progesterone. Cancer cells that are progesterone receptor positive may need progesterone to grow.
39 (Encounter for other screening for malignant neoplasm of breast). Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
Breast Cancer ICD-10 Code Reference SheetFEMALERightC50.811Malignant neoplasm of overlapping sites, right female breastC50.911Malignant neoplasm of unspecified site, right female breastD05.01Lobular carcinoma in situ, right breast9 more rows
A breast cancer is estrogen receptor-positive if it has receptors for estrogen. This suggests that the cancer cells, like normal breast cells, may receive signals from estrogen that tell the cells to grow. The cancer is progesterone receptor-positive if it has progesterone receptors.
The estrogen steroid hormone receptor (ER) and human epithelial growth factor receptor 2 membrane tyrosine kinase growth factor receptor (HER2) are the mediators of two key pathways involved in breast carcinogenesis, invasive behavior and cell growth.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
Z13. 820 Encounter for screening for osteoporosis - ICD-10-CM Diagnosis Codes.
D05. 1 - Intraductal carcinoma in situ of breast | ICD-10-CM.
ICD-10 Code for Unspecified lump in the right breast- N63. 1- Codify by AAPC.
ICD-10 Code for Encounter for breast reconstruction following mastectomy- Z42. 1- Codify by AAPC.
The 2021 edition of ICD-10-CM Z17 became effective on October 1, 2020.
In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere.". Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code.